Thursday, 02 April 2020

China News

  • China to reduce prices of drugs by up to 20%

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2013

    Singapore: After India, now China has decided to cut prices of about 400 drugs for respiratory diseases, fever and pain by up to 20 percent from February 1, 2013. This decision was taken ...Read more

  • First-ever fusion cage launched in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2012

    Singapore: Bonovo Orthopedics launched the first PEEK (PEEK-OPTIMA polymer from INVIBIO) lateral interbody fusion cage, Cross-Fuse in China. Minimally invasive lateral interbody fusion (MIL...Read more

  • Celsion, Hisun Pharma enter tech development deal

    China |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jan, 2013

    Singapore: Celsion, a leading oncology drug development company, and Zhejiang Hisun Pharmaceutical, a leading Chinese pharmaceutical company, have entered into a technology development agr...Read more

  • Consistent clinical trial quality is key for China

    China |  Opinion | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2013

    China's pharmaceutical market has grown steadily in the last few years and is projected to grow by an average 19 percent year-on-year over the next few years, according to Economic Intell...Read more

  • Kimball's China facility achieves ISO certification

    China |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Kimball Electronics Group, a subsidiary of Kimball International, announced that the company's production facility in Nanjing, China, has achieved the stringent ISO 13485 certifi...Read more

  • GSK research paper on China retracted

    China |  News | By BioSpectrum Bureau  | 0 Comment | 10 Dec, 2013

    Singapore: British drug maker GlaxoSmithKline that has been surrounded by unending controversy for allegations made against the company's operations in China has now released a statement. ...Read more

  • Li Xiting appointed CEO of Mindray

    China |  News | By BioSpectrum Bureau  | 0 Comment | 28 Nov, 2012

    Singapore: Mr Xu Hang has resigned from the position of co-chief executive officer (co-CEO) at Mindray Medical International. Mr Xu Hang will, however, remain the company's chairman. Mr Li ...Read more

  • ProMetic to get $10 mn equity from Chinese firm

    China |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

    Singapore: ProMetic Life Sciences has finalized the $10 million strategic equity investment by Shenzhen Hepalink Pharmaceutical pursuant to the terms and conditions previously disclosed on...Read more

  • Bioplasma World Asia 2012 to be held in July

    China |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Recognizing the region's need to work towards self-sufficiency in plasma products, Bioplasma World Asia 2012 will bring together the Asian and international blood plasma communit...Read more

  • Chugai gives cancer drug license to Debiopharm

    China |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2013

    Singapore: Chugai Pharmaceutical and Debiopharm Group entered into a licensing agreement regarding FF284 (called Debio 1347 by Debiopharm), which was discovered by Chugai and is about to e...Read more

  • ASKLEP joins Medidata partner program

    China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

    Singapore: ASKLEP, a leading Tokyo-based provider of clinical research services, has joined the Medidata Solutions Partner Program as part of its strategy to expand its existing offerings ...Read more

  • Medistem in collaboration with China firm subsidiary

    China |  News | By BioSpectrum Bureau  | 0 Comment | 11 Oct, 2012

    Singapore: US-based Medistem has entered into a collaboration with Superview Biotechnology, a subsidiary of Yinhuan Holding from Yixing, China. The joint work will be aimed at using proprie...Read more

  • CHRI issues final termsheet to Herborium

    China |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jun, 2012

    Singapore: China Health Resource Incorporation (CHRI) issued a final termsheet to Herborium Group and is now awaiting response from the group's board of directors. Mr Steve Weiss, director...Read more

  • Sinovac 2012 AGM highlights

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Aug, 2012

    Singapore: Sinovac Biotech, a leading provider of biopharmaceutical products in China, held its 2012 annual general meeting of shareholders on Wednesday, August 22, 2012. The required quoru...Read more

  • Theravance, Alfa Wassermann collaborate

    China |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

    Singapore: Theravance and Alfa Wassermann entered into an exclusive development and commercialization agreement in certain countries for velusetrag, Theravance's investigational 5-HT4 agon...Read more

  • H7N9 bird flu update- 130 cases, 32 deaths

    China |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2013

    Singapore: National Health and Family Planning Commission, China, has notified the WHO of two additional laboratory-confirmed cases of human infection with avian influenza A (H7N9) virus.Un...Read more

  • Garth Tierney is executive VP of INC CRO

    China |  News | By BioSpectrum Bureau  | 0 Comment | 04 Mar, 2013

    Singapore: INC Research has promoted Mr Garth Tierney to executive vice president, Asia Pacific. He will be responsible for driving the strategic development and overall growth of the CRO....Read more

  • Boehringer China sees 32% rise in prescription drugs

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 26 Apr, 2013

    Singapore: Boehringer Ingelheim China's prescription medicine business has outperformed the market with a growth rate of 32 percent in 2012. With core products including Mucosolvan ampoule...Read more